SCHEMBL21709330

SCHEMBL21709330

Nc1cccc2c1-c1ccccc1Cc1ccccc1-c1ccccc1C2

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
KDM4E B2RXH2 1/20 0.52
NPC1 O15118 1/20 0.52
LMNA P02545 1/20 0.52
MAPT P10636 1/20 0.52
HPGD P15428 1/20 0.52
RAB9A P51151 1/20 0.52
HTR2B P41595 1/20 0.45
MAOA P21397 2/20 0.45
ADORA2A P29274 2/20 0.44
PTPRC P08575 1/20 0.44
PNMT P11086 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
POLB P06746 1/20 0.41
DRD2 P14416 1/20 0.40
DRD4 P21917 1/20 0.40
DRD3 P35462 1/20 0.40
CSNK1A1 P48729 3/20 0.39
DYRK1A Q13627 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2048985 0.98 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2KDM4ENPC1LMNA
SCHEMBL29490146 0.98 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2KDM4ENPC1LMNA
SCHEMBL30297184 0.96 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2KDM4ENPC1LMNA
Hydrochloric Acid SCHEMBL2860818 0.96 HTR2B (0.49) ALDH1A1SMN1; SMN2KDM4ENPC1LMNA
Biphenyl SCHEMBL21611806 0.90 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2KDM4ENPC1LMNA
SCHEMBL30681697 0.86 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2KDM4ENPC1LMNA
SCHEMBL18847838 0.86 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2KDM4ENPC1LMNA
SCHEMBL20823399 0.86 MAOA (0.57) ALDH1A1SMN1; SMN2KDM4ENPC1LMNA
SCHEMBL28975183 0.85 PNMT (0.44) ALDH1A1SMN1; SMN2KDM4ENPC1LMNA
SCHEMBL10782961 0.82 MAOA (0.61) ALDH1A1SMN1; SMN2KDM4ENPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200048207-A1 COMPOUNDS WITH ARYLAMINE STRUCTURES MERCK PATENT GMBH (DE) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200048207-A1 COMPOUNDS WITH ARYLAMINE STRUCTURES DDT, NAT1, INMT ALDH1A1 318/4885SMN1; SMN2 3449/4885KDM4E 1144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.